1. Home
  2. YRD vs BCYC Comparison

YRD vs BCYC Comparison

Compare YRD & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yiren Digital Ltd.

YRD

Yiren Digital Ltd.

HOLD

Current Price

$4.51

Market Cap

407.8M

Sector

Finance

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$7.07

Market Cap

438.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YRD
BCYC
Founded
2012
2009
Country
China
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
407.8M
438.4M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
YRD
BCYC
Price
$4.51
$7.07
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$18.73
AVG Volume (30 Days)
75.8K
329.4K
Earning Date
11-25-2025
10-30-2025
Dividend Yield
9.76%
N/A
EPS Growth
N/A
N/A
EPS
2.03
N/A
Revenue
$872,820,262.00
$28,339,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.23
N/A
Revenue Growth
10.41
N/A
52 Week Low
$4.15
$6.03
52 Week High
$8.74
$21.50

Technical Indicators

Market Signals
Indicator
YRD
BCYC
Relative Strength Index (RSI) 36.66 50.66
Support Level $4.27 $6.76
Resistance Level $4.64 $7.83
Average True Range (ATR) 0.21 0.42
MACD 0.02 0.10
Stochastic Oscillator 37.14 58.06

Price Performance

Historical Comparison
YRD
BCYC

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: